Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial.
Miras AD, Pérez-Pevida B, Aldhwayan M, Kamocka A, McGlone ER, Al-Najim W, et al.
Lancet Diabetes Endocrinol. 2019 Jul;7(7):549-559.
http://doi.org/10.1016/S2213-8587(19)30157-3